Drug Utilization Evaluation on the Combination of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Taiwan

被引：0

作者：

Chang, Wen-Yi ^{[1
]}

Chen, Li-Chia ^{[1
,2
]}

Cheng, Li-Jen ^{[3
]}

机构：

[1] Kaohsiung Med Univ, Grad Inst Clin Pharm, Kaohsiung, Taiwan

[2] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham, England

[3] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

335

引用

页码：S143 / S144

页数：2

共 50 条

[1] Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
Shiou-Huei Huang
Chien-Ning Hsu
Shu-Hui Yu
Thau-Ming Cham
BMC Public Health, 12
[2] Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
Huang, Shiou-Huei
Hsu, Chien-Ning
Yu, Shu-Hui
Cham, Thau-Ming
BMC PUBLIC HEALTH, 2012, 12
[3] PRESCRIPTION SWITCHING FROM ANGIOTENSIN-CONVERTING ENZYME INHIBITORS TO ANGIOTENSIN RECEPTOR BLOCKERS IN TAIWAN
Huang, S. H.
Hsu, C. N.
Cham, T. M.
VALUE IN HEALTH, 2012, 15 (07) : A616 - A616
[4] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
Lonn E.
Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
[5] The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors
Sica, DA
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2002, 3 (02) : 66 - 71
[6] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
Kostis, John B.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (04) : 397 - 397
[7] Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
Morton, A. P.
DIABETIC MEDICINE, 2013, 30 (10) : 1263 - 1264
[8] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
Gales, Barry J.
Bailey, Emilee K.
Reed, Ashley N.
Gales, Mark A.
ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
[9] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
Tazkarji, Bachir
Ganeshamoorthy, Ambika
Auten, Beth
AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
[10] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy
Dillon, JJ
SEMINARS IN NEPHROLOGY, 2004, 24 (03) : 218 - 224

← 1 2 3 4 5 →